Article

CURE's Top 5 Stories: August 2019

Author(s):

Jessica Skarzynski

Here are the top five CURE stories for August 2019.

Here are the top five CURE stories for August 2019.

5. Surviving Cancer Has Taught Me to Be Present

In this Share Your Story piece, reader Roberta Lombardi talks about how cancer has made her realize how much of life she let slip by while trying to be in control, and that there is peace in letting that go.

4. Breast Implant-Associated Cancer: What You Need to Know

After the recent FDA-requested recall of certain breast implants given their association with cancer, we spoke with a lymphoma expert about implant removal, reconstruction and the signs of anaplastic large cell lymphoma in this story.

3. Newly Diagnosed? An Expert Offers Advice

We sat down with Elizabeth Franklin, the executive director of the Cancer Policy Institute at the Cancer Support Community, who offered some candid advice for individuals who may be facing a new cancer diagnosis in this interview.

2. Back in Circulation from Lymphedema

Several new surgical options can help reverse or prevent lymphedema by keeping lymph fluid moving through the body. Learn more about them in this feature from our Summer issue.

1. Breaking Free From the ‘Cancer Victim’ Mentality

After a cancer diagnosis, a person's identity may change. Here, contributor Bonnie Annis discusses how familiar cancer terminology such as "patient," "survivor," or even "victim” can form a lasting positive or negative impact on a person's life.

Related Videos
Image of woman with blonde hair.
Image of woman with blonde hair.
Image of woman with brown hair.
a man and a woman in front of a dark blue background
a man and a woman in front of a dark blue background
a man and a woman in separate boxes in front of a dark blue background
Dr. Debu Tripathy discussed the importance of understanding the distinctions between HER2-low and HER2-ultralow breast cancer.
Dr. Debu Tripathy is a professor and chairman of the Department of Breast Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, in Houston, and the editor-in-chief of CURE®.
Related Content
Illustration of woman with red hair.
March 14th 2025

Triple-Positive Breast Cancer Research Saved My Daughter’s Life

Debbie Legault
Cancer research saved my daughter’s life, and despite setbacks, we must support these efforts to ensure more lives are saved from cancer.
FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment
February 5th 2024

FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment

Alex Biese Brielle Benyon
One cancer vaccine may still be years away from being available, a breast cancer test may be misguiding treatments for Black women and the review of two oncology regimens are being expedited by the FDA.
Image of woman with hand on chest.
March 12th 2025

First Patients Enrolled in Trial on Anti-HER2 Therapy in HER2+ Breast Cancer

Spencer Feldman
The first patients have been enrolled in the HEROES trial, exploring de-escalation of anti-HER2 therapy in metastatic HER2+ breast cancer using circulating tumor DNA.
Cancer Horizons podcast logo
December 12th 2023

Conference Highlights from SABCS

Alex Biese Brielle Benyon
CURE® recently covered the San Antonio Breast Cancer Symposium. In case you missed it, here is some news that came out of the conference that patients should know about.
green background with white text indicating FDA Approval, What You Need to Know
March 8th 2025

FDA Approves Biosimilars for Cancer-Related Skeletal Events

Alex Biese
The FDA has approved Stoboclo and Osenvelt to address skeletal issues faced by patients with cancer.
Image of woman holding her chest.
March 7th 2025

BRCA1/2 Mutations May Associate With Better Chemo Response in TNBC

Alex Biese
Among patients with early-stage triple-negative breast cancer, a beneficial pathologic complete response rate was higher in patients with BRCA1/2 mutations.